| Karen Malveaux, MD | |
|
4000 Spencer Hwy, Pasadena, TX 77504-1202 | |
| (713) 359-2000 | |
| (713) 359-1004 |
| Full Name | Karen Malveaux |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Location | 4000 Spencer Hwy, Pasadena, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1699769455 | NPI | - | NPPES |
| 122665603 | Medicaid | TX | |
| 122665607 | Medicaid | TX | |
| 050052104 | Other | TX | RAILROAD MEDICARE |
| 8DP365 | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | H0946 (Texas) | Primary |
| Entity Name | Sound Physicians Anesthesiology Of Texas Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1295356277 PECOS PAC ID: 1254751407 Enrollment ID: O20201009000612 |
News Archive
Results of Eastern Cooperative Oncology Group Phase III clinical trial E4A03, for multiple myeloma, showing significantly better overall survival with lenalidomide plus low-dose dexamethasone therapy compared to lenalidomide plus high-dose dexamethasone, were reported today by S. Vincent Rajkumar, M.D. at the American Society of Hematology's annual meeting.
A research team at the University of California, Riverside, has found exposure to sound - not sound reduction - during early development of mice engineered to have Fragile X Syndrome, or FXS, restores molecular, cellular, and functional properties in the auditory cortex, the area of the brain that processes sounds.
Doctors, patients and the general public depend on results of scientific research to provide information about the safety and effectiveness of medical treatments. Following the controversy surrounding the Andrew Wakefield study on the link between MMR vaccines and autism, the public is now considering the reliability of medical research in Britain today.
The Hain Celestial Group, Inc.,a leading natural and organic products company providing consumers with A Healthy Way of Life, today announced the launch of its co-branded Earth's Best and Zhi Ling Tong organic infant formula in China through its Hutchison Hain Organic Holdings Limited ("Hutchison Hain Organic") joint venture.
A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine.
› Verified 4 days ago
| Entity Name | Crystal Anesthesia Services Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245683309 PECOS PAC ID: 8123430097 Enrollment ID: O20201217001393 |
News Archive
Results of Eastern Cooperative Oncology Group Phase III clinical trial E4A03, for multiple myeloma, showing significantly better overall survival with lenalidomide plus low-dose dexamethasone therapy compared to lenalidomide plus high-dose dexamethasone, were reported today by S. Vincent Rajkumar, M.D. at the American Society of Hematology's annual meeting.
A research team at the University of California, Riverside, has found exposure to sound - not sound reduction - during early development of mice engineered to have Fragile X Syndrome, or FXS, restores molecular, cellular, and functional properties in the auditory cortex, the area of the brain that processes sounds.
Doctors, patients and the general public depend on results of scientific research to provide information about the safety and effectiveness of medical treatments. Following the controversy surrounding the Andrew Wakefield study on the link between MMR vaccines and autism, the public is now considering the reliability of medical research in Britain today.
The Hain Celestial Group, Inc.,a leading natural and organic products company providing consumers with A Healthy Way of Life, today announced the launch of its co-branded Earth's Best and Zhi Ling Tong organic infant formula in China through its Hutchison Hain Organic Holdings Limited ("Hutchison Hain Organic") joint venture.
A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Karen Malveaux, MD Po Box 3945, Dept 841, Houston, TX 77253-3945 Ph: (281) 358-8114 | Karen Malveaux, MD 4000 Spencer Hwy, Pasadena, TX 77504-1202 Ph: (713) 359-2000 |
News Archive
Results of Eastern Cooperative Oncology Group Phase III clinical trial E4A03, for multiple myeloma, showing significantly better overall survival with lenalidomide plus low-dose dexamethasone therapy compared to lenalidomide plus high-dose dexamethasone, were reported today by S. Vincent Rajkumar, M.D. at the American Society of Hematology's annual meeting.
A research team at the University of California, Riverside, has found exposure to sound - not sound reduction - during early development of mice engineered to have Fragile X Syndrome, or FXS, restores molecular, cellular, and functional properties in the auditory cortex, the area of the brain that processes sounds.
Doctors, patients and the general public depend on results of scientific research to provide information about the safety and effectiveness of medical treatments. Following the controversy surrounding the Andrew Wakefield study on the link between MMR vaccines and autism, the public is now considering the reliability of medical research in Britain today.
The Hain Celestial Group, Inc.,a leading natural and organic products company providing consumers with A Healthy Way of Life, today announced the launch of its co-branded Earth's Best and Zhi Ling Tong organic infant formula in China through its Hutchison Hain Organic Holdings Limited ("Hutchison Hain Organic") joint venture.
A drug has shown great promise in the treatment of neuroblastoma, an aggressive form of childhood cancer. The study was led by researchers at Lund University in Sweden, and is published in the journal Science Translational Medicine.
› Verified 4 days ago
Dr. Reagan M Poland, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4000 Spencer Hwy, Pasadena, TX 77504 Phone: 713-359-2000 | |
Tyce Lee Regan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 3315 Burke Rd, #300, Pasadena, TX 77504 Phone: 713-944-5151 | |
Ken Lee Thrasher, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4301 Vista Rd Bldg A, Pasadena, TX 77504 Phone: 713-378-3066 Fax: 713-378-3077 | |
John Paul Aquilina, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4000 Spencer Highway, Pasadena, TX 77504 Phone: 713-359-2000 Fax: 713-359-1004 | |
Mr. Andre George Albu, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 5010 Crenshaw Rd, Ste. #130, Pasadena, TX 77505 Phone: 281-991-2200 Fax: 281-991-7700 | |
Hieu T. Pham, D.O. Anesthesiology Medicare: Medicare Enrolled Practice Location: 5010 Crenshaw Rd, Ste. #130, Pasadena, TX 77505 Phone: 281-991-2211 Fax: 281-991-7700 | |
Dr. Chris Taigo Fuke, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 5010 Crenshaw Rd, Ste. #130, Pasadena, TX 77505 Phone: 281-991-2200 Fax: 281-991-7700 |